other material
confidence high
sentiment positive
materiality 0.45
Niagen Bioscience increases share repurchase authorization to $20M from $10M
Niagen Bioscience, Inc.
- Board approved increase of share repurchase program from $10M to $20M.
- Approximately $2.6M of common stock repurchased through March 17, 2026.
- Program runs through October 31, 2027, unless modified or terminated.
- CEO Rob Fried cited conviction in strategy and long-term value.